Evidence map›Paper›PMID 29377632›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2018

The effects of brain death and ischemia on tolerance induction are organ-specific.

S G Michel, M L L Madariaga, G M LaMuraglia, V Villani, M Sekijima, E A Farkash, R B Colvin, D H Sachs, K Yamada, B R Rosengard and 2 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Association of Procurement Time With Pancreas Transplant Outcomes in Brain-Dead Donors.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  3. Article
  4. Review
  5. Frontiers in immunology · 2021
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

S G MichelCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
M L L MadariagaCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
G M LaMuragliaCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
V VillaniCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-6078-9766
M SekijimaCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
E A FarkashDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
R B ColvinDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
D H SachsCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
K YamadaDepartment of Surgery, Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA.
B R RosengardJohnson and Johnson, New Brunswick, NJ, USA.
J S AllanCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
J C MadsenCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Massachusetts General Hospital · USColumbia University Irving Medical Center · USEmory University · USJohnson & Johnson (United States) · USKagoshima University · JPUniversity of Michigan · US

Funding

XENOGENIC TOLERANCE IN MICEP01HL018646 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1985 to 2019
$37.5M
Project 3: The Role of Erythropoietin in Kidney Transplant ToleranceP01AI123086 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HEEGER, PETER SCOTT · 2016 to 2020
$10.6M
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantationU01AI131470 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 2017 to 2022
$5.6M
RES FACIL CONST: XENOTRANSPLANTATION, LUNG ALLOGRAFT REJECTION IN SWINEC06RR020135 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI SLAVIN, PETER L · 2004 to 2004
$2.7M
Tolerance to Vascularized Allografts in MiniswineR56AI031046 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SACHS, DAVID H · 2017 to 2017
$733k
C4d-independent diagnosis of chronic antibody mediated renal allograft rejectionK23AI108951 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FARKASH, EVAN A · 2014 to 2018
$706k
AMELIORATION OF THE DELETERIOUS EFFECTS OF DONOR BRAIN DEATHF32HL117540 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MADARIAGA, MARIA LUCIA · 2013 to 2014
$110k
NCRR NIH HHS C06 RR020135NHLBI NIH HHS F32 HL117540NHLBI NIH HHS P01 HL018646NIAID NIH HHS K23 AI108951NIAID NIH HHS P01 AI123086NIAID NIH HHS R56 AI031046NIAID NIH HHS U01 AI131470
6 · The paper itself

Abstract

We have previously shown that 12 days of high-dose calcineurin inhibition induced tolerance in MHC inbred miniature swine receiving MHC-mismatched lung, kidney, or co-transplanted heart/kidney allografts. However, if lung grafts were procured from donation after brain death (DBD), and transplanted alone, they were rejected within 19-45 days. Here, we investigated whether donor brain death with or without allograft ischemia would also prevent tolerance induction in kidney or heart/kidney recipients. Four kidney recipients treated with 12 days of calcineurin inhibition received organs from donors rendered brain dead for 4 hours. Six heart/kidney recipients also treated with calcineurin inhibition received organs from donors rendered brain dead for 4 hours, 8 hours, or 4 hours with 4 additional hours of cold storage. In contrast to lung allograft recipients, all isolated kidney or heart/kidney recipients that received organs from DBD donors achieved long-term survival (>100 days) without histologic evidence of rejection. Proinflammatory cytokine gene expression was upregulated in lungs and hearts, but not kidney allografts, after brain death. These data suggest that the deleterious effects of brain death and ischemia on tolerance induction are organ-specific, which has implications for the application of tolerance to clinical transplantation.

Indexed as

Heart TransplantationKidney TransplantationLung TransplantationAnimalsBrain DeathCytokinesGraft RejectionGraft SurvivalIschemiaOrgan SpecificitySwineSwine, MiniatureTissue DonorsTransplantation ToleranceCytokinesanimal models: porcineheart transplantation/cardiologykidney transplantation/nephrologylung transplantation/pulmonologyrejectiontolerance: experimentaltranslational research/science

Identifiers

PMID29377632
PMCPMC5910264
OpenAlexW2791939928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.